Biopharmaceuticals and gene vectors opening new avenues in cancer immune therapy

Ther Deliv. 2016 Jul;7(7):419-22. doi: 10.4155/tde-2016-0032.
No abstract available

Keywords: cancer; cancer gene therapy; immune checkpoint inhibitors; oncolytic virus.

Publication types

  • Editorial

MeSH terms

  • Animals
  • Biological Products / administration & dosage
  • Biological Products / immunology*
  • Biopharmaceutics
  • Genetic Therapy / trends*
  • Genetic Vectors / administration & dosage
  • Genetic Vectors / genetics
  • Genetic Vectors / immunology*
  • Humans
  • Immunotherapy / trends*
  • Neoplasms / genetics
  • Neoplasms / immunology*
  • Neoplasms / therapy
  • Oncolytic Virotherapy / trends

Substances

  • Biological Products